Global Drug Repurposing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Drug Repurposing market size was valued at USD 25280 million in 2023 and is forecast to a readjusted size of USD 30620 million by 2030 with a CAGR of 2.8% during review period.
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Drug Repurposing industry chain, the market status of Hospitals (Oncology, CNS Diseases), Ambulatory Surgical Centers (Oncology, CNS Diseases), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Repurposing.
Regionally, the report analyzes the Drug Repurposing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Repurposing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Repurposing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Repurposing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology, CNS Diseases).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Repurposing market.
Regional Analysis: The report involves examining the Drug Repurposing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Repurposing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Repurposing:
Company Analysis: Report covers individual Drug Repurposing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Repurposing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Drug Repurposing. It assesses the current state, advancements, and potential future developments in Drug Repurposing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Repurposing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug Repurposing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Drug Repurposing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Repurposing, with revenue, gross margin and global market share of Drug Repurposing from 2019 to 2024.
Chapter 3, the Drug Repurposing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Repurposing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Repurposing.
Chapter 13, to describe Drug Repurposing research findings and conclusion.
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Drug Repurposing industry chain, the market status of Hospitals (Oncology, CNS Diseases), Ambulatory Surgical Centers (Oncology, CNS Diseases), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Repurposing.
Regionally, the report analyzes the Drug Repurposing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Repurposing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Repurposing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Repurposing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology, CNS Diseases).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Repurposing market.
Regional Analysis: The report involves examining the Drug Repurposing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Repurposing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Repurposing:
Company Analysis: Report covers individual Drug Repurposing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Repurposing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Drug Repurposing. It assesses the current state, advancements, and potential future developments in Drug Repurposing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Repurposing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug Repurposing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Oncology
- CNS Diseases
- Neurodegenerative Diseases
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
- Astellas Pharma
- Biovista
- Novartis
- AbbVie
- Pfizer
- Allergan
- NuMedii
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Drug Repurposing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Repurposing, with revenue, gross margin and global market share of Drug Repurposing from 2019 to 2024.
Chapter 3, the Drug Repurposing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Repurposing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Repurposing.
Chapter 13, to describe Drug Repurposing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Drug Repurposing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Repurposing by Type
1.3.1 Overview: Global Drug Repurposing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Drug Repurposing Consumption Value Market Share by Type in 2023
1.3.3 Oncology
1.3.4 CNS Diseases
1.3.5 Neurodegenerative Diseases
1.3.6 Others
1.4 Global Drug Repurposing Market by Application
1.4.1 Overview: Global Drug Repurposing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Others
1.5 Global Drug Repurposing Market Size & Forecast
1.6 Global Drug Repurposing Market Size and Forecast by Region
1.6.1 Global Drug Repurposing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Drug Repurposing Market Size by Region, (2019-2030)
1.6.3 North America Drug Repurposing Market Size and Prospect (2019-2030)
1.6.4 Europe Drug Repurposing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Drug Repurposing Market Size and Prospect (2019-2030)
1.6.6 South America Drug Repurposing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Drug Repurposing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Drug Repurposing Product and Solutions
2.1.4 Astellas Pharma Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Astellas Pharma Recent Developments and Future Plans
2.2 Biovista
2.2.1 Biovista Details
2.2.2 Biovista Major Business
2.2.3 Biovista Drug Repurposing Product and Solutions
2.2.4 Biovista Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biovista Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Drug Repurposing Product and Solutions
2.3.4 Novartis Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Drug Repurposing Product and Solutions
2.4.4 AbbVie Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Drug Repurposing Product and Solutions
2.5.4 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Drug Repurposing Product and Solutions
2.6.4 Allergan Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Allergan Recent Developments and Future Plans
2.7 NuMedii
2.7.1 NuMedii Details
2.7.2 NuMedii Major Business
2.7.3 NuMedii Drug Repurposing Product and Solutions
2.7.4 NuMedii Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 NuMedii Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Repurposing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Drug Repurposing by Company Revenue
3.2.2 Top 3 Drug Repurposing Players Market Share in 2023
3.2.3 Top 6 Drug Repurposing Players Market Share in 2023
3.3 Drug Repurposing Market: Overall Company Footprint Analysis
3.3.1 Drug Repurposing Market: Region Footprint
3.3.2 Drug Repurposing Market: Company Product Type Footprint
3.3.3 Drug Repurposing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Repurposing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Drug Repurposing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Repurposing Consumption Value Market Share by Application (2019-2024)
5.2 Global Drug Repurposing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Drug Repurposing Consumption Value by Type (2019-2030)
6.2 North America Drug Repurposing Consumption Value by Application (2019-2030)
6.3 North America Drug Repurposing Market Size by Country
6.3.1 North America Drug Repurposing Consumption Value by Country (2019-2030)
6.3.2 United States Drug Repurposing Market Size and Forecast (2019-2030)
6.3.3 Canada Drug Repurposing Market Size and Forecast (2019-2030)
6.3.4 Mexico Drug Repurposing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Drug Repurposing Consumption Value by Type (2019-2030)
7.2 Europe Drug Repurposing Consumption Value by Application (2019-2030)
7.3 Europe Drug Repurposing Market Size by Country
7.3.1 Europe Drug Repurposing Consumption Value by Country (2019-2030)
7.3.2 Germany Drug Repurposing Market Size and Forecast (2019-2030)
7.3.3 France Drug Repurposing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Drug Repurposing Market Size and Forecast (2019-2030)
7.3.5 Russia Drug Repurposing Market Size and Forecast (2019-2030)
7.3.6 Italy Drug Repurposing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Repurposing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Drug Repurposing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Drug Repurposing Market Size by Region
8.3.1 Asia-Pacific Drug Repurposing Consumption Value by Region (2019-2030)
8.3.2 China Drug Repurposing Market Size and Forecast (2019-2030)
8.3.3 Japan Drug Repurposing Market Size and Forecast (2019-2030)
8.3.4 South Korea Drug Repurposing Market Size and Forecast (2019-2030)
8.3.5 India Drug Repurposing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Drug Repurposing Market Size and Forecast (2019-2030)
8.3.7 Australia Drug Repurposing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Drug Repurposing Consumption Value by Type (2019-2030)
9.2 South America Drug Repurposing Consumption Value by Application (2019-2030)
9.3 South America Drug Repurposing Market Size by Country
9.3.1 South America Drug Repurposing Consumption Value by Country (2019-2030)
9.3.2 Brazil Drug Repurposing Market Size and Forecast (2019-2030)
9.3.3 Argentina Drug Repurposing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Repurposing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Drug Repurposing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Drug Repurposing Market Size by Country
10.3.1 Middle East & Africa Drug Repurposing Consumption Value by Country (2019-2030)
10.3.2 Turkey Drug Repurposing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Drug Repurposing Market Size and Forecast (2019-2030)
10.3.4 UAE Drug Repurposing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Drug Repurposing Market Drivers
11.2 Drug Repurposing Market Restraints
11.3 Drug Repurposing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Repurposing Industry Chain
12.2 Drug Repurposing Upstream Analysis
12.3 Drug Repurposing Midstream Analysis
12.4 Drug Repurposing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Drug Repurposing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Repurposing by Type
1.3.1 Overview: Global Drug Repurposing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Drug Repurposing Consumption Value Market Share by Type in 2023
1.3.3 Oncology
1.3.4 CNS Diseases
1.3.5 Neurodegenerative Diseases
1.3.6 Others
1.4 Global Drug Repurposing Market by Application
1.4.1 Overview: Global Drug Repurposing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Others
1.5 Global Drug Repurposing Market Size & Forecast
1.6 Global Drug Repurposing Market Size and Forecast by Region
1.6.1 Global Drug Repurposing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Drug Repurposing Market Size by Region, (2019-2030)
1.6.3 North America Drug Repurposing Market Size and Prospect (2019-2030)
1.6.4 Europe Drug Repurposing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Drug Repurposing Market Size and Prospect (2019-2030)
1.6.6 South America Drug Repurposing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Drug Repurposing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Drug Repurposing Product and Solutions
2.1.4 Astellas Pharma Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Astellas Pharma Recent Developments and Future Plans
2.2 Biovista
2.2.1 Biovista Details
2.2.2 Biovista Major Business
2.2.3 Biovista Drug Repurposing Product and Solutions
2.2.4 Biovista Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biovista Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Drug Repurposing Product and Solutions
2.3.4 Novartis Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Drug Repurposing Product and Solutions
2.4.4 AbbVie Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Drug Repurposing Product and Solutions
2.5.4 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Drug Repurposing Product and Solutions
2.6.4 Allergan Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Allergan Recent Developments and Future Plans
2.7 NuMedii
2.7.1 NuMedii Details
2.7.2 NuMedii Major Business
2.7.3 NuMedii Drug Repurposing Product and Solutions
2.7.4 NuMedii Drug Repurposing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 NuMedii Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Repurposing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Drug Repurposing by Company Revenue
3.2.2 Top 3 Drug Repurposing Players Market Share in 2023
3.2.3 Top 6 Drug Repurposing Players Market Share in 2023
3.3 Drug Repurposing Market: Overall Company Footprint Analysis
3.3.1 Drug Repurposing Market: Region Footprint
3.3.2 Drug Repurposing Market: Company Product Type Footprint
3.3.3 Drug Repurposing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Repurposing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Drug Repurposing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Repurposing Consumption Value Market Share by Application (2019-2024)
5.2 Global Drug Repurposing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Drug Repurposing Consumption Value by Type (2019-2030)
6.2 North America Drug Repurposing Consumption Value by Application (2019-2030)
6.3 North America Drug Repurposing Market Size by Country
6.3.1 North America Drug Repurposing Consumption Value by Country (2019-2030)
6.3.2 United States Drug Repurposing Market Size and Forecast (2019-2030)
6.3.3 Canada Drug Repurposing Market Size and Forecast (2019-2030)
6.3.4 Mexico Drug Repurposing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Drug Repurposing Consumption Value by Type (2019-2030)
7.2 Europe Drug Repurposing Consumption Value by Application (2019-2030)
7.3 Europe Drug Repurposing Market Size by Country
7.3.1 Europe Drug Repurposing Consumption Value by Country (2019-2030)
7.3.2 Germany Drug Repurposing Market Size and Forecast (2019-2030)
7.3.3 France Drug Repurposing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Drug Repurposing Market Size and Forecast (2019-2030)
7.3.5 Russia Drug Repurposing Market Size and Forecast (2019-2030)
7.3.6 Italy Drug Repurposing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Repurposing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Drug Repurposing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Drug Repurposing Market Size by Region
8.3.1 Asia-Pacific Drug Repurposing Consumption Value by Region (2019-2030)
8.3.2 China Drug Repurposing Market Size and Forecast (2019-2030)
8.3.3 Japan Drug Repurposing Market Size and Forecast (2019-2030)
8.3.4 South Korea Drug Repurposing Market Size and Forecast (2019-2030)
8.3.5 India Drug Repurposing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Drug Repurposing Market Size and Forecast (2019-2030)
8.3.7 Australia Drug Repurposing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Drug Repurposing Consumption Value by Type (2019-2030)
9.2 South America Drug Repurposing Consumption Value by Application (2019-2030)
9.3 South America Drug Repurposing Market Size by Country
9.3.1 South America Drug Repurposing Consumption Value by Country (2019-2030)
9.3.2 Brazil Drug Repurposing Market Size and Forecast (2019-2030)
9.3.3 Argentina Drug Repurposing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Repurposing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Drug Repurposing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Drug Repurposing Market Size by Country
10.3.1 Middle East & Africa Drug Repurposing Consumption Value by Country (2019-2030)
10.3.2 Turkey Drug Repurposing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Drug Repurposing Market Size and Forecast (2019-2030)
10.3.4 UAE Drug Repurposing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Drug Repurposing Market Drivers
11.2 Drug Repurposing Market Restraints
11.3 Drug Repurposing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Repurposing Industry Chain
12.2 Drug Repurposing Upstream Analysis
12.3 Drug Repurposing Midstream Analysis
12.4 Drug Repurposing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Drug Repurposing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drug Repurposing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Drug Repurposing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Drug Repurposing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 6. Astellas Pharma Major Business
Table 7. Astellas Pharma Drug Repurposing Product and Solutions
Table 8. Astellas Pharma Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Astellas Pharma Recent Developments and Future Plans
Table 10. Biovista Company Information, Head Office, and Major Competitors
Table 11. Biovista Major Business
Table 12. Biovista Drug Repurposing Product and Solutions
Table 13. Biovista Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biovista Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Drug Repurposing Product and Solutions
Table 18. Novartis Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. AbbVie Company Information, Head Office, and Major Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Drug Repurposing Product and Solutions
Table 23. AbbVie Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. AbbVie Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Drug Repurposing Product and Solutions
Table 28. Pfizer Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Allergan Company Information, Head Office, and Major Competitors
Table 31. Allergan Major Business
Table 32. Allergan Drug Repurposing Product and Solutions
Table 33. Allergan Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Allergan Recent Developments and Future Plans
Table 35. NuMedii Company Information, Head Office, and Major Competitors
Table 36. NuMedii Major Business
Table 37. NuMedii Drug Repurposing Product and Solutions
Table 38. NuMedii Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. NuMedii Recent Developments and Future Plans
Table 40. Global Drug Repurposing Revenue (USD Million) by Players (2019-2024)
Table 41. Global Drug Repurposing Revenue Share by Players (2019-2024)
Table 42. Breakdown of Drug Repurposing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Drug Repurposing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 44. Head Office of Key Drug Repurposing Players
Table 45. Drug Repurposing Market: Company Product Type Footprint
Table 46. Drug Repurposing Market: Company Product Application Footprint
Table 47. Drug Repurposing New Market Entrants and Barriers to Market Entry
Table 48. Drug Repurposing Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Drug Repurposing Consumption Value (USD Million) by Type (2019-2024)
Table 50. Global Drug Repurposing Consumption Value Share by Type (2019-2024)
Table 51. Global Drug Repurposing Consumption Value Forecast by Type (2025-2030)
Table 52. Global Drug Repurposing Consumption Value by Application (2019-2024)
Table 53. Global Drug Repurposing Consumption Value Forecast by Application (2025-2030)
Table 54. North America Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 55. North America Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 56. North America Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 57. North America Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 58. North America Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 59. North America Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 60. Europe Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Europe Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Europe Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 63. Europe Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 64. Europe Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 67. Asia-Pacific Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 68. Asia-Pacific Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 69. Asia-Pacific Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 70. Asia-Pacific Drug Repurposing Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Asia-Pacific Drug Repurposing Consumption Value by Region (2025-2030) & (USD Million)
Table 72. South America Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 73. South America Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 74. South America Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 75. South America Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 76. South America Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 77. South America Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Middle East & Africa Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 79. Middle East & Africa Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 80. Middle East & Africa Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 81. Middle East & Africa Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 82. Middle East & Africa Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 83. Middle East & Africa Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Drug Repurposing Raw Material
Table 85. Key Suppliers of Drug Repurposing Raw Materials
Table 1. Global Drug Repurposing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drug Repurposing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Drug Repurposing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Drug Repurposing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 6. Astellas Pharma Major Business
Table 7. Astellas Pharma Drug Repurposing Product and Solutions
Table 8. Astellas Pharma Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Astellas Pharma Recent Developments and Future Plans
Table 10. Biovista Company Information, Head Office, and Major Competitors
Table 11. Biovista Major Business
Table 12. Biovista Drug Repurposing Product and Solutions
Table 13. Biovista Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biovista Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Drug Repurposing Product and Solutions
Table 18. Novartis Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. AbbVie Company Information, Head Office, and Major Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Drug Repurposing Product and Solutions
Table 23. AbbVie Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. AbbVie Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Drug Repurposing Product and Solutions
Table 28. Pfizer Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Allergan Company Information, Head Office, and Major Competitors
Table 31. Allergan Major Business
Table 32. Allergan Drug Repurposing Product and Solutions
Table 33. Allergan Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Allergan Recent Developments and Future Plans
Table 35. NuMedii Company Information, Head Office, and Major Competitors
Table 36. NuMedii Major Business
Table 37. NuMedii Drug Repurposing Product and Solutions
Table 38. NuMedii Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. NuMedii Recent Developments and Future Plans
Table 40. Global Drug Repurposing Revenue (USD Million) by Players (2019-2024)
Table 41. Global Drug Repurposing Revenue Share by Players (2019-2024)
Table 42. Breakdown of Drug Repurposing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Drug Repurposing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 44. Head Office of Key Drug Repurposing Players
Table 45. Drug Repurposing Market: Company Product Type Footprint
Table 46. Drug Repurposing Market: Company Product Application Footprint
Table 47. Drug Repurposing New Market Entrants and Barriers to Market Entry
Table 48. Drug Repurposing Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Drug Repurposing Consumption Value (USD Million) by Type (2019-2024)
Table 50. Global Drug Repurposing Consumption Value Share by Type (2019-2024)
Table 51. Global Drug Repurposing Consumption Value Forecast by Type (2025-2030)
Table 52. Global Drug Repurposing Consumption Value by Application (2019-2024)
Table 53. Global Drug Repurposing Consumption Value Forecast by Application (2025-2030)
Table 54. North America Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 55. North America Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 56. North America Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 57. North America Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 58. North America Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 59. North America Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 60. Europe Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Europe Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Europe Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 63. Europe Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 64. Europe Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 67. Asia-Pacific Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 68. Asia-Pacific Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 69. Asia-Pacific Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 70. Asia-Pacific Drug Repurposing Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Asia-Pacific Drug Repurposing Consumption Value by Region (2025-2030) & (USD Million)
Table 72. South America Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 73. South America Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 74. South America Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 75. South America Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 76. South America Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 77. South America Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Middle East & Africa Drug Repurposing Consumption Value by Type (2019-2024) & (USD Million)
Table 79. Middle East & Africa Drug Repurposing Consumption Value by Type (2025-2030) & (USD Million)
Table 80. Middle East & Africa Drug Repurposing Consumption Value by Application (2019-2024) & (USD Million)
Table 81. Middle East & Africa Drug Repurposing Consumption Value by Application (2025-2030) & (USD Million)
Table 82. Middle East & Africa Drug Repurposing Consumption Value by Country (2019-2024) & (USD Million)
Table 83. Middle East & Africa Drug Repurposing Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Drug Repurposing Raw Material
Table 85. Key Suppliers of Drug Repurposing Raw Materials
LIST OF FIGURES
Figure 1. Drug Repurposing Picture
Figure 2. Global Drug Repurposing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drug Repurposing Consumption Value Market Share by Type in 2023
Figure 4. Oncology
Figure 5. CNS Diseases
Figure 6. Neurodegenerative Diseases
Figure 7. Others
Figure 8. Global Drug Repurposing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Drug Repurposing Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Others Picture
Figure 13. Global Drug Repurposing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Drug Repurposing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Drug Repurposing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Drug Repurposing Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Drug Repurposing Consumption Value Market Share by Region in 2023
Figure 18. North America Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Drug Repurposing Revenue Share by Players in 2023
Figure 24. Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Drug Repurposing Market Share in 2023
Figure 26. Global Top 6 Players Drug Repurposing Market Share in 2023
Figure 27. Global Drug Repurposing Consumption Value Share by Type (2019-2024)
Figure 28. Global Drug Repurposing Market Share Forecast by Type (2025-2030)
Figure 29. Global Drug Repurposing Consumption Value Share by Application (2019-2024)
Figure 30. Global Drug Repurposing Market Share Forecast by Application (2025-2030)
Figure 31. North America Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 41. France Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Drug Repurposing Consumption Value Market Share by Region (2019-2030)
Figure 48. China Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 51. India Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 65. Drug Repurposing Market Drivers
Figure 66. Drug Repurposing Market Restraints
Figure 67. Drug Repurposing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Drug Repurposing in 2023
Figure 70. Manufacturing Process Analysis of Drug Repurposing
Figure 71. Drug Repurposing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Drug Repurposing Picture
Figure 2. Global Drug Repurposing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drug Repurposing Consumption Value Market Share by Type in 2023
Figure 4. Oncology
Figure 5. CNS Diseases
Figure 6. Neurodegenerative Diseases
Figure 7. Others
Figure 8. Global Drug Repurposing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Drug Repurposing Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Others Picture
Figure 13. Global Drug Repurposing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Drug Repurposing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Drug Repurposing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Drug Repurposing Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Drug Repurposing Consumption Value Market Share by Region in 2023
Figure 18. North America Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Drug Repurposing Revenue Share by Players in 2023
Figure 24. Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Drug Repurposing Market Share in 2023
Figure 26. Global Top 6 Players Drug Repurposing Market Share in 2023
Figure 27. Global Drug Repurposing Consumption Value Share by Type (2019-2024)
Figure 28. Global Drug Repurposing Market Share Forecast by Type (2025-2030)
Figure 29. Global Drug Repurposing Consumption Value Share by Application (2019-2024)
Figure 30. Global Drug Repurposing Market Share Forecast by Application (2025-2030)
Figure 31. North America Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 41. France Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Drug Repurposing Consumption Value Market Share by Region (2019-2030)
Figure 48. China Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 51. India Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Drug Repurposing Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Drug Repurposing Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Drug Repurposing Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Drug Repurposing Consumption Value (2019-2030) & (USD Million)
Figure 65. Drug Repurposing Market Drivers
Figure 66. Drug Repurposing Market Restraints
Figure 67. Drug Repurposing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Drug Repurposing in 2023
Figure 70. Manufacturing Process Analysis of Drug Repurposing
Figure 71. Drug Repurposing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
